Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene

Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene

US Patent 11786554 · Granted Oct 17, 2023

Estimated economic value: $300,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Display panel and method of fabricating the same2025
Transcription factor NCgl0581 mutant and use thereof in L-serine detection2025
Application of compound amino acids in preparation of medicament for improving s2025
Optimized engineered meganucleases having specificity for a recognition sequence2025
Optimized engineered meganucleases having specificity for a recognition sequence2025
Rationally-designed single-chain meganucleases with non-palindromic recognition 2025
Methods for producing a complex transgenic trait locus2025
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
RNA nanoparticles and method of use thereof2024